PhaseBio Pharmaceuticals, Inc. (PHAS)
CapEx to Revenue
24734.56%
TTM · Retrieved:
PHAS CapEx to Revenue
Current (TTM)24734.56%retrieved
Current (TTM)24734.56%retrieved
PHAS TTM CapEx/Revenue (24734.56% → 24734.56%)
Latest values, visible window
More history is needed to export this chart.
PHAS capex to revenue history
Published TTM snapshot. The date records when this current TTM value was retrieved.
| Retrieved | CapEx to Revenue |
|---|---|
| 24,734.5582% |